Table 3.
Treatments and outcomes of 18 hospitalized COVID-19 patients in Zhongnan Hospital of Wuhan University, China.
| All patients (n = 18) | |
|---|---|
| Treatments—n (%) | |
| Antiviral therapy | 17 (94.4) |
| Antibiotics | 18 (100) |
| Antifungal | 4 (22.2) |
| Corticosteroids | 11 (61.1) |
| Gamma globulin | 4 (22.2) |
| Thymosin | 2 (11.1) |
| Blood transfusion | 4 (22.2) |
| Oxygen uptake | 18 (100) |
| Continuous renal replacement therapy | 7 (38.9) |
| Non-invasive mechanical ventilation | 15 (83.3) |
| Invasive mechanical ventilation | 11 (61.1) |
| Extracorporeal membrane oxygenation (ECMO) | 1 (5.6) |
| Complications—n (%) | |
| ARDS | 17 (94.4) |
| AKI | 7 (38.9) |
| Shock | 6 (33.3) |
| Acute cardiac injury | 10 (55.6) |
| Gastrointestinal bleeding | 1 (5.6) |
| Perforation of intestine | 1 (5.6) |
Values are numbers (percentage) unless stated otherwise.